Potassium: an ion with dangerous airs and graces

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Potassium balance is vital for cellular function.
• Electrolyte disturbances, specifically hypokalaemia and hyperkalaemia, are common complications in patients with chronic heart failure (CHF) and chronic kidney disease (CKD).
• These imbalances can lead to significant morbidity and mortality.

Purpose of the Study:

• To elucidate the primary factors contributing to the development of hypokalaemia.
• To identify the main drivers of hyperkalaemia.
• To provide a comprehensive overview of potassium dysregulation in the context of CHF and CKD.

Main Methods:

• Review of existing literature and clinical data.
• Analysis of patient cohorts with CHF and CKD.
• Identification of common physiological and iatrogenic causes of potassium imbalance.

Main Results:

• Factors promoting hypokalaemia include diuretic use, certain medications, and gastrointestinal losses.
• Factors promoting hyperkalaemia involve impaired renal excretion, medication side effects (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics), and dietary intake.
• Specific disease states like advanced CKD and decompensated CHF significantly increase risk.

Conclusions:

• Effective management of CHF and CKD requires vigilant monitoring and management of serum potassium levels.
• Understanding the specific etiological factors is essential for targeted therapeutic interventions.
• Prevention and treatment strategies should address both underlying disease processes and external contributing factors.